Surgery Partners Inc(SGRY) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services, and optical services. It also operates optical laboratory that manufactures eyewear. As of March 31, 2020, the company owned or operated a portfolio of 127 surgical facilities, including 111 ambulatory surgical centers and 16 surgical hospitals in 30 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Current Price

$51.61

RSI

68.441

Beta:

3.162713

March 10, 2021
2.9B
-6.2M

6.013 %
0.432 %
56.667 %
-372.464 %

$1,860,100,000
$1,831,400,000
$1,771,456,000
$1,341,219,000
$1,145,438,000
$959,891,000
1.567 %
3.384 %
32.078 %
17.092 %
19.330 %

$-18,800,000
$54,600,000
$-69,165,000
$82,286,000
$92,178,000
$-76,137,000
-390.426 %
226.676 %
-218.971 %
-12.021 %
182.598 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.